The role of leukocytes in tissue injury

European Journal of Anaesthesiology

Volumn 13, Issue 3, 1996, Pages 235-246

  Crockett Torabi, E ^a   Ward, P A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adhesion molecules; Inflammation; Inflammatory mediators; Leukocytes; Tissue injury

Indexed keywords

ACETYLSALICYLIC ACID DERIVATIVE; CHEMOKINE; COMPLEMENT; CYTOKINE; GROWTH FACTOR; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE; REACTIVE OXYGEN METABOLITE;

CELL ADHESION; ENDOTHELIUM CELL; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE; MEDIATOR; PATHOGENESIS; REVIEW; TISSUE INJURY; VASCULAR ENDOTHELIUM;

EID: 0029934288     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199605000-00003     Document Type: Review

References (131)

1. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophil endothelial cell adhesion in inflammatory disorders. J Crit Care 1994; 9: 1-26.
2. Lehr HA, Menger MD, Mersmer K. Impact of leukocyte adhesion on myocardial ischemta/reperfusion injury: conceivable mechanisms and proven facts. J Lab Clin Med 1993; 121: 539-545.
3. Fantone JC, Feltner De, Brieland JL, Ward PA. Phagocytic cell derived inflammatory mediators and lung disease. Chest 1987; 91: 428-435.
4. Ward PA, Warren JS, Varani J, Johnson KJ. PAF, cytokines, toxic oxygen products and cell injury. Molec Aspects Med 1991; 12: 169-174.
5. Smith JA. Neutrophils, host defense, and inflammation: a double edge sword. J Leuk Biol 1994; 56: 672-686.
6. Altieri DC. Proteases and protease receptors in modulation of leukocyte effector functions. J Leuk Biol 1995; 58: 120-127.
7. Baggiolini M. Activation and recruitment of neutrophil leukocyte. Clin Exp Immunol 1995; 101 suppl 1: 5-6.
8. Cochrane CG. Mechanisms coupling stimulation and function in leukocytes. Fed Proc Nat Acad Sci 1984; 43: 2729-2731.
9. Smith CW. Transendothelial migration. In: Harlan JM, Liv DY, eds. Adhesion: Its Role in Inflammatory Disease. New York: Freeman, 1992: 63-98.
10. Kiritsy CP, Lynch AB, Lynch SE. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol 1993; 4: 729-760.
11. Deuel TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophilsto platelet derived growth factor. J Clin Invest 1982; 69: 1054-1064.
12. Drake WT, Isseckutz AC. Transforming growth factor Beta 1 enhances polymorphonuclear leukocyte accumulation in dermal inflammation and transendothelial migration by priming action, Immunol 1993; 78: 197-204.
13. Garner WL, Rodriguez JL, Miller JM et al. Acute skin injury releases neutrophil chemoattractants. Surgery 1994; 116: 42-48.
14. Siegbahn A, Hammacher A, Westermark B, Heldin CH. Differential effects of the various isoforms of plateletderived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest 1990; 85: 916-920.
15. Cavaillon JM. Cytokines and macrophages. Biomed Pharmacol 1994; 48: 445-453.
16. Unemori EN, Ferrara N, Baver EA, Amento VP. Vascular endothelial growth factor induces interstitial collegenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557-562.
17. Ahuja SK, Gao Ji-L, Murphy PM. Chemokine receptors and molecular mirnicry, Immunol Today 1994; 15: 281-287.
18. Schall TJ. The cytokines. In: Thomson AW, ed. The Cytokine Handbook. London: Academic Press. 1994: 419-460.
19. Crockett-Torabi E, Fantone JC. Signal transduction and adhesion molecules, in: Ward PA, Fantone JC, eds. Adhesion Molecules and the Lung. New York: Marcel Dekker, Inc. 1996. (In press.)
20. Reiner NE. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today 1994; 15: 374-381.
21. Hallett MB, Lloyds D. Neutrophil priming: the cellular signals that say 'amber' but not 'green', Immunol Today 1995; 16: 264-268.
22. Edwards SW, Watson F. The cell biology of phagocytes. Immunol Today 1995; 16: 508-510.
23. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J 1995; 9: 200-209.
24. Fantone JC, Ward PA. Role of oxygen derived free radicals and metabolites, in leukocyte dependent inflammation reactions. Am J Pathol 1982; 107: 397-418.
25. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radical in ischemia myocardial injury. J Mol Cell Cardiol 1989; 21: 1241-1251.
26. Scales WE, Campbell Jr DA, Green ME, Remick DG. Hepatic ischemia/reperfusion injury: importance of oxidant/tumor necrosis factor interactions. Am J Physiol 1994; 267: G1122-G1127.
27. Spector RA. Oxidative stress induced cataract: mechanisms of action. FASEB J 1995; 9: 1173-1182.
28. Ward PA, Varani J. Mechanisms of neutrophil-mediated killing of endothelial cells. J Leukoc Biol 1990; 48: 97-102.
29. Dreyer WJ, Michael LH, West MS et al. Neutrophil accumulation in ischemiccanine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 1991; 84: 400-411.
30. Mullane KM, Smith CW. The role of leukocytes in ischemic damage, reperfusion injury and repair of the myocardium. In: Piper HM, ed. Pathophysiology of Severe Ischemic Myocardial Injury. Dordrecht: Kluwer Academic Publishers, 1990: 239-267.
31. Entman ML, Youker K, Shoji T et al. Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 1992; 90: 1335-1345.
32. Slezak J, Tribulova N, Pristacova J et al. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol 1995; 147: 772-781.
33. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728.
34. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-1330.
35. Stevens C. Is nitric oxide the "retrograde messenger"? Science 1991; 254: 1296-1297.
36. Beckman JS, BeckmanTW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
37. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994; 55: 662-675.
38. Clancy R, Leszczynska J, Amin A, Levartovsky D, Abramson SB. Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils. J Leukoc Biol 1995; 38: 196-202.
39. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation, Immunol Today 1995; 16: 128-130.
40. Boughton-Smith NK, Evans SM, Hawkey CJ et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 338-340.
41. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992; 51: 1219-1222.
42. Koprowski H, Zheng YM, Heber-Katz E et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases (published erratum appears in Proc Natl Acad Sci USA 1993; 90: 5378) Proc Natl Acad Sci USA 1993; 90: 3024-3027.
43. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992; 587: 250-256.
44. Iatenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211: 177-182.
45. McCartney-Francis N, Allen JB, Mizel DE et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178: 749-754.
46. Weinberger JB, Granger DL Pisetsky DS et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-1pr/1pr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179: 651-660.
47. Mulligan MS, Hevel JM, Marletta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 1991; 88: 6338-6342.
48. DeCaterina R, Libby P, Peng H-B et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
49. Tsuji M, Dimov VB, Yoshida T. In vivo expression of monokine and inducible nitric oxide synthase in experimentally induced pulmonary granulomatous inflammation. Evidence of sequential production of interleukin-1 inducible nitric oxide synthase and tumor necrosis factor. Am J Path 1995; 147: 1001-1015.
50. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
51. Murray HW, Teitelbaum RF. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis 1992; 155: 513-517.
52. Maeda H, Akaike T, Yoshida M, Suga M. Multiple functions of nitric oxide in pathophysioiogy and microbiology: analysis by a new nitric oxide scavenger. J Leuk Biol 1994; 56: 588-592.
53. Salvemini D, Manning PT, Zweifel BS et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995; 96: 301-308.
54. Xie Q, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 1994; 56: 576-582.
55. Pascual M, French LE. Complement in human diseases: looking towards the 21st century, Immunol Today 1995; 16: 58-61.
56. Webster RO, Hong SR, Johnston Jr RB, Henson PM. Biological effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology 1980; 2: 201-219.
57. Frank MM. Complement in the pathophysiology of human disease. N Engl J Med 1987; 316: 1525-1530.
58. Myrvang Hogasen AK, Wurzner R, Abrahamsen TG, Dierich MP. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6 which may be released on stimulation. J Immunol 1995; 154: 4734-4740.
59. Gasque P, Fontaine M, Morgan BP. Complement expression in human glial cells and cell lines. J Immunol 1995; 154: 4726-4733.
60. Gasque P, Chan P, Fontaine M et al. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J Immunol 1995; 155: 4882-4889.
61. Morgan BP. Complement regulatory molecules: application to therapy and transplantation, Immunol Today 1995; 16: 257-259.
62. Mulligan MS, Yeh CG, Rudolph AR, Ward PA. Protective effects of soluble CR1 in complement- and neutrophilmediated tissue injury. J Immunol 1992; 148: 1479-1485.
63. Zimmerman GA, Renzetti AD, Hill HR. Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1983; 127: 290-300.
64. Furie MB, Randolph GJ. Chemokines and tissue injury review. Am J Path 1995; 146: 1287-1301.
65. Kennedy J, Keiner GS, Kleyensteuber S et al. Molecular cloning and functional characterization of human lymphotactin. J Immunol 1995; 155: 203-209.
66. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 1993; 71: 9B-14B.
67. Edgington SM. Chemokines in cardiovascular disease: do chemoattractant cytokines regulate the progression of atherosclerosis? Biol Technol 1993; 11: 676-679.
68. Strieter RM, Koch AE, Antony VB, Pick Jr RB, Standiford TJ, Kunkel SL The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med 1994; 123: 183-197.
69. Schroder JM. Peptides and cytokines. Arch Dermatol Res 1992; 284 Suppl 1: S22-S26.
70. Kunkel SL, Lukacs NW, Strieter RM. The role of interleukin-8 in the infectious process. Ann NY Acad Sci 1994; 730: 134-143.
71. Schlondorff D. Potential role of chemotactic cytokines in glomerular injury. Clin Invest 1993; 71: 815-816.
72. Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 194; 20: 473-490.
73. Lukacs NW, Strieter RM, Kunkel SL. Leukocyte infiltration in Allergic Airway Inflammation. Am J Respir Cell Mol Biol 1995; 13: 1-6.
74. Smith RE, Strieter RM, Zhang K et al. A role of C-C chemokines in fibrotic lung disease. J Leukoc Biol 1995; 57: 782-787.
75. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994; 56: 559-564.
76. Mulligan MS, Jones ML, Bolanowski MA et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993; 150: 5585-5595.
77. Jones ML, Mulligan MS, Flory CM, Ward PA, Warren JS. Potential role of monocyte chemoattractant protein 1/JE in monocyte/macrophage-dependent IgA immune complex alveolitis in the rat. J Immunol 1992; 149: 2147-2154.
78. Flory CM, Jones ML, Warren JS. Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1. Lab Invest 1993; 69: 396-404.
79. Vilcek J, Le J, Le J. Immunology of cytokines: an introduction. In: Thomson AW, ed. The Cytokine Handbook, London: Academic Press, 1991: 1-17.
80. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16: 21-26.
81. Stadnyk AW. Cytokine production by epithelial cells. FASEB J 1994; 8: 1041-1047.
82. Cotran RS, Pober JS. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol 1990; 1: 225-235.
83. Young HA, Hardy KJ. Role of interferon-gamma immune cell regulation. J Leuk Biol 1995; 58: 373-381.
84. Oppenheim JJ. Summary of the fifth conference on the molecular mechanisms and physiological activities of cytokines. J Leukoc Biol 1994; 56: 687-691.
85. Taga T, Kishimoto T. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr Opin Immunol 1995; 7: 17-23.
86. Larrick JW, Wright SC. Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J 1990; 4: 3215-3223.
87. Maury CP, Teppo AM. Raised serum levels of cachectin/ tumor necrosis factor alpha in renal allograft rejection. J Exp Med 1987; 166: 1132-1127.
88. Flory CM, Jones ML, Miller BF, Warren JS. Regulatory roles of tumor necrosis factor-a and interleukin-1-B in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am J Path 1995; 146: 450-462.
89. Warren JS. Intrapulmonary interleukin 1 mediates acute immune complex alveolitis in the rat. Biochem Biophys Res Commun 1991; 175: 604-610.
90. Lukacs NW, Chensue SW, Strieter RM, Warmington K, Kunkel SL. Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1. J Immunol 1994; 152: 5883-5889.
91. Remick DG. Cytokines and septic shock. Bailliere's Clinical Infectious Diseases. 1994; 1: 37-50.
92. Nickoloff B. Cytokine Networks; immunobiology surfaces proposed cytokine interactions in psoriasis. J NIH Res 1991; 3: 71-74.
93. Moulin V. Growth factors in skin wound healing. Europ J Cell Biol 1995; 68: 1-7.
94. Remick DG, Colletti LM, Scales WA, McCurry KR, Campbell Jr DA. Cytokines and extrahepatic sequelae of ischemia-reperfusion injury to the liver. Ann NY Acad Sci 1994; 723: 271-283.
95. Remick DG. Significance of in vivo detection of tumor necrosis factor (editorial; comment). Lab Invest 1991; 65: 259-261.
96. Saxne T, Palladino Jr MA, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31: 1041-1045.
97. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases, Immunol Today 1995; 16: 383-386.
98. Fujita S, Arii S, Moden et al. Participation of hepatic macrophages and plasma factors in endotoxin-induced liver injury. J Surgical Res 1995; 69: 263-270.
99. Mulligan MS, Ward PA. Immune complex-induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor-alpha and IL-1. J Immunol 1992; 149: 331-339.
100. Warren JS, Yabroff KR, Remick DG et al. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 1989; 84: 1873-1882.
101. Mulligan MS, Vaporciyan AA, Warner RL et al. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J Immonl 1995; 154: 1350-1363.
102. Remick DG, Kunkel SL Pathophysiologic alterations induced by tumor necrosis factor, Int Rev Exp Pathol 199; 34 Pt B: 7-25.
103. Waage A. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin Immunol Immunopathol 1987; 45: 348-355.
104. Tracy KJ, Beutler B, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
105. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986; 232: 977-980.
106. Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK. Neutrophils contribute to hepatic ischemiareperfusion injury by a CD 18-independent mechanism. J Leukoc Biol 1993; 53: 511-517.
107. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone Jr MA. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985; 76: 2003-2011.
108. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Regulatory effects of intrinsic IL-10 in IgG immune complex-inducted lung injury. J Immunol 1995; 154: 3454-3460.
109. Van Hal PT, Hopstaken-Broos JP, Prins A et al. Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2). J Immunol 1994; 163: 2718-2728.
110. Berg DJ, Leach MW, Kuhn R et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995; 182: 99-108.
111. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 1993; 685: 713-739.
112. Gearing AJ, Beckett P, Christodoulou M et al. Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol 1995; 57: 774-777.
113. Klein B, Brailly H. Cytokine-binding proteins: stimulating antagonists, Immunol Today 1995; 16: 216-219.
114. Bar-Shavit R, Kahn A, Wilner GD, Fenton JW. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 1983; 220: 728-731.
115. Zimmerman GA, Mclntyre TM, Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985; 76: 2235-2246.
116. Crockett-Torabi E, Fantone JC. Trie selectins: insight into selectin-induced intracellular signaling in leukocytes. Immunol Res 1996. (In press.)
117. Katsuda S, Okada Y, Okada Y, Imai K, Nakanishi I. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Am J Pathol 1994; 145: 1208-1218.
118. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992; 7: 120-125.
119. Pereira HA. CAP37, a neutrophil-derived multifunctional inflammatory mediator. J Leukoc Biol 1995; 57: 805-812.
120. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 995; 16: 417-419.
121. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J 1994; 8: 929-938.
122. Crockett-Torabi E, Sullenbarger B, Smith CW, Fantone J. Activation of human neutrophil through L-selectin and mac-1 molecules. J Immunol 1995; 154: 2291-2302.
123. Rosales C, Juliano RL. Signal transduction by cell adhesion receptors in leukocytes. J Leukoc Biol 1995; 57: 189-198.
124. Gorski A. The role of cell adhesion molecules in immunopathology. Immunol Today 1994; 15: 251-255.
125. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-512.
126. Noris M, Remuzzi G. New insights into circulating cellendotheuum interactions and their significance for glomerular pathophysiology. Am J Kidney Dis 1995; 26: 541-548.
127. Till GO, Lee S, Mulligan MS et al. Adhesion molecules in experimental phacoanaphylaetic endophthalmitis. Invest Ophthalmol Vis Sci 1992; 33: 3417-3423.
128. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leuk Biol 1995; 57: 368-374.
129. Man KT, Sharar SR, Phillips ML, Harlan JM, Winn RK. Sialyl Lewis X oligosaccharide reduces ischemia-reperfusion injury in the rabbit ear. J Immunol 1995; 155: 4011-4015.
130. Barnard JW, Biro MC, Lo SK et al. Neutrophil inhibitory factor prevents neutrophil-dependent lung injury. J Immunol 1995; 155: 4876-4881.
131. Cronstein BN, Weissmann G. Targets for antiinflammatory drugs. Annu Rev Pharmacol Toxicol 1995; 35: 449-462.